Moderna Is Fighting Pfizer, BioNTech over mRNA Patent

thedailyupside.com Harry Truman once said, “’It is amazing what you can accomplish if you do not care who gets the credit.” After one pandemic, a medical breakthrough, and millions of lives…

Covid vaccine makers to clash in London over mRNA patent dispute

ft.com Moderna alleges Pfizer and BioNTech infringed its patents in use of mRNA platform

Moderna CEO says AI will help scientists understand ‘most diseases’ in 3 to 5 years

semafor.com The News Moderna CEO Stéphane Bancel said Thursday that with the help of AI scientists will likely “understand most diseases” in the next three to five years, in what will…

Semafor unveils expansion of flagship live journalism platform 'The World Economy Summit: Fall Edition'

semafor.com The News Today, on stage at the Semafor World Economy Summit in Washington D.C, Co-Founder & CEO, Justin B. Smith announced the launch of its inaugural World Economy Summit:…

How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution

aol.com When Brad Miller became the chief information officer at drugmaker Moderna in early 2023, he already had a strong background in finance and technology, but no expertise in…

The top 15 companies for career growth if you work in the US, according to LinkedIn

businessinsider.com JPMorgan Chase & Co. Leonardo Munoz/VIEWpress/Corbis via Getty Images LinkedIn published a ranking of the best large companies for career growth in the US. Amazon ranked No.…

Aaron Rodgers' HIV comments spark furious backlash

newsweek.com Comments Aaron Rodgers previously made about HIV have resurfaced online, resulting in furious backlash from social media users. During an appearance on the Look Into It with…

American stocks loiter near an all-time high

economist.com It is the first trading day of the year. The stockmarket opens a whisker away from an all-time high. American equities have soared over the past 12 months, up by around 25%,…

Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff

benzinga.com On Tuesday, Johnson & Johnson JNJ delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while…

Many of LinkedIn’s top 50 companies for 2024 are already using AI to empower employees

fastcompany.com LinkedIn has published its annual ranking of top companies based on career growth. The 2024 list features 50 honorees—all companies that are offering their employees what…

2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential

finance.yahoo.com Artificial intelligence (AI) has caught the eye of investors because of its potential to transform many industries, and the biggest impact could be in the area of…

2 Stocks Down 30% to Buy Right Now

finance.yahoo.com The bull market is roaring higher, and many growth stocks have led the gains -- but this doesn't mean your opportunity to buy growth stocks for a good price is over. Plenty…

CDC Study Doesn't 'Debunk' Link Between COVID-19 Vaccines & Sudden-Deaths

zerohedge.com CDC Study Doesn't 'Debunk' Link Between COVID-19 Vaccines & Sudden-Deaths Authored by Zachary Stieber via The Epoch Times, A new U.S. Centers for Disease Control and…

Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges

cnbc.com Moderna on Thursday said it has paused plans to build a vaccine manufacturing site in Kenya after a steep drop in demand for its Covid vaccines. The biotech company said it…

Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans

benzinga.com Famed COVID-19 vaccine maker Moderna Inc MRNA has decided to pause its plans to construct a vaccine manufacturing plant in Kenya, signaling a shift away from investing in…

Moderna puts Kenya plant plans on hold as COVID vaccine demand slumps

aol.com Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for COVID-19 vaccines. The…

Up 6% on Upbeat Data From Cancer Jab Study

benzinga.com Shares of Moderna MRNA rose 6.2% on Apr 9 after management announced encouraging data from a portion of an early-stage study on mRNA-4157/V940, its investigational…

Hopes rise for mRNA cancer vaccine after Moderna trial shows promise

semafor.com Semafor Signals Supported by Insights from Live Science, Nature, and Axios The News Hopes for a successful cancer vaccine were boosted this week after pharma company Moderna…

Moderna Inches Nearer to Successful Cancer Vaccine

thedailyupside.com Moderna may just have another shot at glory. On Tuesday, the ascendant biopharma player announced positive results in an early-stage trial of the individualized cancer…

Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?

investorplace.com These rocket-fueled growth stocks were market darlings four years ago The 2024 presidential election is shaping up to be just as exciting and contentious the 2020 contest.…